Your Cart

ONLY for order: aweaas@pm.me

Free worldwide shipping on all orders over $300.00

Browse

Want to chat?

ONLY for order: aweaas@pm.me

INFORMATION

  • Recipes
  • Step by step
  • Is it possbile?
  • Rate us
  • Need help?
mk 677 powder ibutamoren mesylate powder

MK 677 Powder Ibutamoren Mesylate Raw

MK 677 powder is a product which acts as a potent, orally active GH secretagogue, mimicking the GH stimulating action of the endogenous hormone ghrelin.

MK 677 powder in stock
Alias: L-163,191
M.Wt: 624.77
Formula: C27H36N4O5S
MK 677 powder solubility: DMSO
MK 677 powder Purity: >99%
MK 677 powder Storage: at 20℃ 2 years
Half life: 24 hours
CAS No.: 159752-10-0

Minimum order quantity: 10 grams.
Competitive offers will be provided according to your detailed orders.

MK-677-powder-Test Report #04087
MK-677-powder-Test Report #04087

General information of MK 677 powder ibutamoren mesylate powder.

MK 677 powder (Ibutamoren mesylate, L-163,191) is a sarm which acts as a potent, orally active growth hormone secretagogue, mimicking the GH stimulating action of the endogenous hormone ghrelin. MK 677 powder has been demonstrated to increase the release of, and produces sustained increases in plasma levels of several hormones including growth hormone and IGF-1, but without affecting cortisol levels. It is currently under development as a potential treatment for reduced levels of these hormones, such as in growth hormone deficient children or elderly adults.

And human studies have shown it to increase both muscle mass and bone mineral density, making it a promising therapy for the treatment of frailty in the elderly.It also alters metabolism of body fat and so may have application in the treatment of obesity.
Some MK 677 powders study shows the suggested mk 677 dosage is 25 mgs-50 mgs when it is the oral.

Administration of MK 677 25 mg resulted in a 60.1% increase in serum IGF-1 levels at 6 weeks and a 72.9% increase at 12 months. In mixed-effects models that included treatment, time (month), randomization strata (baseline MMSE score ≤20 vs >20), and interaction of treatment-by-time, there were no significant differences between the treatment groups on the CIBIC-plus or the mean change from baseline scores on the ADAS-Cog, ADCS-ADL, or CDR-sob scores over 12 months.

>> We offer professional help for pill pressing or capsule filling.
>> We love hearing from you for any of questions or queries you may have.

Send an Inquiry Now.

Please enable JavaScript in your browser to complete this form.
Leave a Reply
0588f3da902f5b99b8d1220f6a4c680ae46a2a8c4b4cf6eadc8c544b4492fbeb4a
Request a Quote Form
Please enable JavaScript in your browser to complete this form.
Please make sure the emaill address is correct, or we're not able to get in touch in time.
No format hassle.